Extracellular Matrix Proteins and Tumor Angiogenesis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Tumor development is a complex process that relies on interaction and communication between a number of cellular compartments. Much of the mass of a solid tumor is comprised of the stroma which is richly invested with extracellular matrix. Within this matrix are a host of matricellular proteins that regulate the expression and function of a myriad of proteins that regulate tumorigenic processes. One of the processes that is vital to tumor growth and progression is angiogenesis, or the formation of new blood vessels from preexisting vasculature. Within the extracellular matrix are structural proteins, a host of proteases, and resident pro- and antiangiogenic factors that control tumor angiogenesis in a tightly regulated fashion. This paper discusses the role that the extracellular matrix and ECM proteins play in the regulation of tumor angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184 · cited 2×
“Combining vessel normalization with chemotherapy would provide better tissue perfusion of cytotoxic agents which induce apoptosis of the tumor [164].”
BackgroundInduction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879 · cited 1×
“Tumors require the ability to establish an angiogenic phenotype, which occurs via the angiogenic switch [9].”
BackgroundSaksela, O., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.767 · Cited by 539 · cited 1×
“Proteases involved in degrading the ECM and often activated during remodelling can promote angiogenesis by stimulating migration of endothelial cells or by releasing proangiogenic growth factors [32, 33].”
Francis, S. E., Goh, K. L., Hodivala-Dilke, K., Bader, B. L., Stark, M., Davidson, D., & Hynes, R. O. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000016045.93313.f2 · Cited by 282
Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor.
Walker, A., Turnbull, J. E., & Gallagher, J. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42201-0 · Cited by 200 · cited 1×
“HSGAGs that are present on the surface of endothelial cells have the ability to either inhibit or promote neovascularization by mediating signalling through VEGF receptors [27] or bFGF [28, 29].”
BackgroundGreenaway, J., Moorehead, R., Shaw, P., & Petrik, J. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.10.035 · Cited by 100 · cited 2×
“The importance of the interaction between the epithelial cells and the tumor stroma is apparent as this interaction causes a reprogramming of the epithelial cells, increasing their metastatic potential; when the tumorigenic epithelial cells were injected intraperitoneally instead of orthotopically, the lack of stromal…”
BackgroundSelf-citation
Cited by
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
RNA-binding protein nucleolin in disease
Abdelmohsen, K., & Gorospe, M. (2012) · RNA Biology · doi:10.4161/rna.19718 · Cited by 272
Molecular imaging of the tumor microenvironment
Zhou, Z., & Lu, Z.-R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.012 · Cited by 253
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
Taubenberger, A. V., Bray, L. J., Haller, B., Shaposhnykov, A., Binner, M., Freudenberg, U., Guck, J., & Werner, C. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.03.017 · Cited by 139
Metadata
- Authors
- Campbell, N. E., Kellenberger, L., Greenaway, J., Moorehead, R. A., Linnerth-Petrik, N. M., & Petrik, J.
- Venue
- Journal of Oncology
- Publisher
- Wiley
- Published
- 2010
- Volume
- 2010
- Pages
- 1-13
- ISSN
- 1687-8450 (ISSN-L)
- 1687-8469
- OpenAlex
- W1995562870
- Cited by
- 101
- References
- 6
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.